Articles with public access mandates - Ranjan DuttaLearn more
Not available anywhere: 4
Axonal loss in multiple sclerosis: causes and mechanisms
G Criste, B Trapp, R Dutta
Handbook of clinical neurology 122, 101-113, 2014
Mandates: US National Institutes of Health
Neuroprotective Agents: An Overview on the General Modes of Action
C Volsko, R Dutta
Neuroprotective Natural Products: Clinical Aspects and Mode of Action, 7-21, 2017
Mandates: US National Institutes of Health
Axonal loss and Neurodegeneration in multiple sclerosis
R Dutta, J Chen, N Ohno, D Ontaneda, BD Trapp
Neurodegeneration, 238-247, 2017
Mandates: US National Institutes of Health
Is Multiple Sclerosis a Neurodegenerative Disorder?
R Dutta, BD Trapp
Blue books of neurology 35, 371-387, 2010
Mandates: US National Institutes of Health
Available somewhere: 46
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
R Dutta, BD Trapp
Progress in neurobiology 93 (1), 1-12, 2011
Mandates: US National Institutes of Health
Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4
Z Chen, W Jalabi, KB Shpargel, KT Farabaugh, R Dutta, X Yin, GJ Kidd, ...
Journal of Neuroscience 32 (34), 11706-11715, 2012
Mandates: US National Institutes of Health
Succination inactivates gasdermin D and blocks pyroptosis
F Humphries, L Shmuel-Galia, N Ketelut-Carneiro, S Li, B Wang, ...
Science 369 (6511), 1633-1637, 2020
Mandates: US National Institutes of Health
Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients
R Dutta, A Chang, MK Doud, GJ Kidd, MV Ribaudo, EA Young, RJ Fox, ...
Annals of neurology 69 (3), 445-454, 2011
Mandates: US National Institutes of Health
Microglial displacement of inhibitory synapses provides neuroprotection in the adult brain
Z Chen, W Jalabi, W Hu, HJ Park, JT Gale, GJ Kidd, R Bernatowicz, ...
Nature communications 5 (1), 4486, 2014
Mandates: Multiple Sclerosis Society of Canada
Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination
L Kirby, J Jin, JG Cardona, MD Smith, KA Martin, J Wang, H Strasburger, ...
Nature communications 10 (1), 3887, 2019
Mandates: US National Institutes of Health
Epigenome-wide differences in pathology-free regions of multiple sclerosis–affected brains
JL Huynh, P Garg, TH Thin, S Yoo, R Dutta, BD Trapp, V Haroutunian, ...
Nature neuroscience 17 (1), 121-130, 2014
Mandates: US National Institutes of Health, Multiple Sclerosis Society, UK
Relapsing and progressive forms of multiple sclerosis: insights from pathology
R Dutta, BD Trapp
Current opinion in neurology 27 (3), 271-278, 2014
Mandates: US National Institutes of Health
Cortical remyelination: a new target for repair therapies in multiple sclerosis
A Chang, SM Staugaitis, R Dutta, CE Batt, KE Easley, AM Chomyk, ...
Annals of neurology 72 (6), 918-926, 2012
Mandates: US National Institutes of Health
Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR‐124 and reduced AMPA receptors
R Dutta, AM Chomyk, A Chang, MV Ribaudo, SA Deckard, MK Doud, ...
Annals of neurology 73 (5), 637-645, 2013
Mandates: US National Institutes of Health
Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation
P Bhargava, MD Smith, L Mische, E Harrington, KC Fitzgerald, K Martin, ...
The Journal of clinical investigation 130 (7), 3467-3482, 2020
Mandates: US National Institutes of Health
Human myelin proteome and comparative analysis with mouse myelin
A Ishii, R Dutta, GM Wark, SI Hwang, DK Han, BD Trapp, SE Pfeiffer, ...
Proceedings of the National Academy of Sciences 106 (34), 14605-14610, 2009
Mandates: US National Institutes of Health
pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis
D Kremer, J Gruchot, V Weyers, L Oldemeier, P Göttle, L Healy, J Ho Jang, ...
Proceedings of the National Academy of Sciences 116 (30), 15216-15225, 2019
Mandates: US National Institutes of Health, German Research Foundation
Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome
S Jawaid, GJ Kidd, J Wang, C Swetlik, R Dutta, BD Trapp
Glia 66 (4), 789-800, 2018
Mandates: US National Institutes of Health
Promoting remyelination in multiple sclerosis: current drugs and future prospects
D Kremer, P Küry, R Dutta
Multiple Sclerosis Journal 21 (5), 541-549, 2015
Mandates: German Research Foundation
DNA methylation in demyelinated multiple sclerosis hippocampus
AM Chomyk, C Volsko, A Tripathi, SA Deckard, BD Trapp, RJ Fox, R Dutta
Scientific reports 7 (1), 8696, 2017
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program